Novartis exercises put option for GSK to buy rest of consumer health JV for $13bn

28 Mar 2018

GlaxoSmithKline PLC paid $13bn to acquire the 36.5% ownership stake held by Novartis AG in their consumer health joint venture.

Acquisition
- Divestiture/Spin-Out
- Partial Acquisition
- Payment Includes Cash

Already a Biomedtracker subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com

Related Companies

Novartis exercises put option for GSK to buy rest of consumer health JV for $13bn

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice